Abstract: ICR-derived glomerulonephritis (ICGN) mice are a novel inbred
Introduction
ICR-derived glomerulonephritis (ICGN) mice are a novel inbred strain with a hereditary nephrotic syndrome and are considered a good animal model of human idiopathic nephrotic syndrome [1] or nephritis [3, 4, 16] . ICGN mice show proteinuria at a young age, later develop hypoproteinemia, hyperlipidemia, anemia, and systemic edema [10, 11, 14] . Previous studies by Ogura et al. [10, 11] and Yamaguchi et al. [15] showed that ICGN mice might develop severe anemia because of progressive renal parenchymal damages. It was demonstrated that peritubular cells are renal erythropoietin-producing cells [2, 5] . Severe anemia in ICGN mice is related to the regression of erythropoietin-producing cells [8, 9, 12, 13] . Unknown tubulointerstitial cells undergoing apoptosis were similar to renal erythropoietin-producing cells detected by in situ hybridization for erythropoietin mRNA [8, 9] , and could be identified as these cells [15] . In the present study, we investigated the effect of the human erythropoietin (hEPO) treatment on the erythrocyte count in 10-week old ICGN mice.
Materials and Methods

Animals and treatments
ICGN mice from the National Institute of Infectious Diseases (NIID, Tokyo, Japan) were prepared by mating homozygous males (nep/nep) and heterozygous females (nep/-) at Kyoto University (Kyoto, Japan). The animals were housed in autoclaved metal cages and were given a standard diet (CM: Oriental Yeast, Japan) and tap water ad libitum in an air-conditioned room (23 ± 1°C) under controlled lighting conditions (12 h light/ 12 h dark). In this experiment, ten ICGN male mice that exhibited proteinuria were used at 10 weeks of age. Five ICGN mice were injected subcutaneously with hEPO (Sigma, USA) at a dose of 5 U/body/day in saline for 5 days, and the other five male mice were not treated and used as control.
Hematology
Hematological parameters were determined in plasma samples from blood obtained from the heart under anesthesia with pentobarbital sodium 1 day after the final hEPO treatment. An Automated Hematology Analyzer K-4500 (Sysmex Co., Japan) was used to determine leukocyte counts (WBC), erythrocyte counts (RBC), platelet counts (PLT), hemoglobin concentration (Hb), hematocrit value (Ht), mean corpuscular volume (MCV), mean corpuscular hematocrit (MCH) and mean corpuscular hematocrit concentration (MCHC).
Blood chemistry
Blood chemical markers were determined in plasma samples from blood obtained from the heart under anesthesia with pentobarbital sodium 1 day after the final hEPO treatment. An Automatic Analyzer 7070 (Hitachi Instruments Service Co., Ltd, Japan) and Autosera kits were used to determine the total protein (burette method), albumin (BCG method), glucose (hexokinase method), BUN (urease-GLDH method), and creatinine (Jaffe's method) levels.
Histopathology
The mice were euthanized 1 day after the final hEPO treatment. Then the kidneys and femur were quickly removed and fixed in 10% buffered formalin. After fixation, the femur was immersed in 10% buffered EDTA for decalcification, and all organs were rinsed in tap water, dehydrated in a graded alcohol series, embedded in paraffin, and cut into sections 5-µm thick. Cross-sections were used for hematoxylin-eosin staining. Histopathological changes were observed under a light microscope, and graded as no remarkable change, slight, moderate or marked.
Statistical analysis
All measured values were analyzed by one-way ANOVA and comparison by Student's t-test or AspinWelch's t-test. The correlation between RBC and creatinine levels was calculated by regression analysis.
Results
Hematology and blood chemistry
Ht was significantly increased in the hEPO-treated mice, and the RBC and Hb were slightly increased compared with those in the control (Table 1) . Other parameters (WBC, MCV, MCH, MCHC, PLT) did not differ in the hEPO-treated mice ( Table 1) .
The total protein level was significantly increased in the hEPO-treated mice, and the albumin level was more increased compared with the control (Table 2) . However, the BUN and glucose levels were less than those in the control ( Table 2 ). The creatinine level was not changed in the hEPO-treated mice.
The correlation coefficient (r=0.040435) between the RBC value and the creatinine level was not significant (p=0.189).
Histopathology
Glomerulosclerosis, basophilic tubules, hyalin casts in tubules, interstitial fibrosis and interstitial lymphocyte infiltration of the kidneys were observed in the hEPO-treated mice and controls, with no difference between the two groups (Table 3) .
There was no remarkable histological difference of the bone marrow in the femur between the two groups ( Table 3) .
Discussion
The effect of the hEPO treatment on anemia was investigated in 10-week old ICGN mice.
The RBC, Hb and Ht values in control ICGN mice were lower than those in normal ICR mice of the same age (in-house data: RBC, 882.0 ± 55.2; Hb, 14.57 ± 0.88; Ht, 48.71 ± 2.61). The MCV value which exhibits hemoconcentration, was not significantly changed after the hEPO treatment. We suggest that ICGN mice showed renal anemia as reported by Ogura et al. [10, 11] and Yamaguchi-Yamada et al. [15] . RBC, Hb and Ht values were increased in the hEPO-treated mice and were similar to the levels found in normal ICR mice. These results indicate that the hEPO treatment improved anemia in the ICGN mice by inducing proliferation of erythrocytes. Renal anemia in ICGN mice may be induced by a decrease in endogenous erythropoietin synthesis. It was reported that the sites of EPO synthesis were mainly peritubular capillary interstitial cells in the kidneys [2, 5, 7] . Since the major biological effects of EPO promote the proliferation or differentiation of proerythroblasts and inhibit apoptosis of erythroblasts [6, 9] , hEPO treatment may improve anemia in ICGN mice. The increased thickness of the fused glomerular basement membrane (GBM) by excessive accumulation of basement membrane material secreted from epithelial cells and subsequent following overall loss of epithelial foot processes in the glomeruli in newborn ICGN mice indicates that the nephrotic disease in ICGN mice is caused by some defects in the GBM maturation process, which may be crucial for the generation of glomerular permselectivity [10] . In the present study, we observed some histopathological findings such as interstitial fibrosis, glomerulosclerosis and hyaline casts in control and hEPO-treated mice similar to the findings in previous studies [10, 11] . This spontaneous disease is similar to human nephrotic syndrome caused by idiopathic glomerular lesions [10] . There was no difference in these renal lesions between control mice and hEPO-treated ones showing amelioration of anemia. In addition, there was no correlation between the creatinine level and the RBC value. These findings suggest that hEPO may not improve renal injury but directly induces erythropoiesis in ICGN mice. Therefore, anemia may be caused by decreased production of EPO following the progression of parenchymal damage in ICGN mice.
